no data available
no data available
no data available
no data available
no data available
ABRAMS world trade wiki as a partner of UN Comtrade (database of the United Nations) as well as the OECD (Organisation for Economic Co-operation and Development) analyzes billions of statistical data as well as freight and customs data using intelligent algorithms as well as Artificial Intelligence (AI) and has developed a "unique business intelligence portal" on this basis (quote UN Comtrade / References).
On this page you will get insights into the market activities of PT Combined Imperial Pharmaceutical which have been individually prepared by our research team.
ABRAMS world trade wiki not only shows direct suppliers and buyers of the first tier (Tier-1). Our tool Supply Chain Intelligence breaks the visibility barrier beyond Tier-1, enabling a comprehensive insight into the entire supply chain network, providing multi-tier transparency with just one click.
Generally you can differentiate the supply chain or supply network of PT Combined Imperial Pharmaceutical by two perspectives:
To ensure business stability and continuity, a supply chain or supply network must be constructed in such a way that external influences can cause as little damage as possible to PT Combined Imperial Pharmaceutical. This applies both in the area of procurement (the loss of a supplier must be covered by an alternative supplier) as in the area of sales (the loss of a buyer must be covered by an alternative buyer).
Risks can generally be considered as the non-availability of goods, through cutback or complete halt of production, or the potential loss of business partners, violating compliance rules (e.g. protection of the environment, labor legislation) and thus drop out of the supply network.
This risk should not necessarily be limited to the direct business partner (Tier 1), it involves the entire supply chain, unless sufficient alternative suppliers and buyers have been put in place.
Get an overview of the international supply chain of PT Combined Imperial Pharmaceutical (upstream/procurement and downstream/sales) from Tier-1 to Tier-n
ABRAMS world trade wiki not only shows direct suppliers and customers of the first tier (Tier-1). With just one click in our tool Supply Chain Intelligence you get a comprehensive insight into the supply network with multiple tiers (Tier-n) beyond the first tier.
Each tier in the supply chain or supply network on the supplier side of PT Combined Imperial Pharmaceutical involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.
If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:
Analyze the potential of shortening and therefore stabilizing the supply chain of PT Combined Imperial Pharmaceutical
Based on the analysis of international bills of lading (bill of lading/bills of lading / BOL), 1 product category that has been purchased by PT Combined Imperial Pharmaceutical can be identified by means of HS codes (HTS codes or customs tariff numbers).
It is classified with the HS code 293750, which groups following products:
„Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, used primarily as hormones". This HS code was sighted 1 time in total.
Get an overview of internationally purchased products by PT Combined Imperial Pharmaceutical with Company Transparency
Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as PT Combined Imperial Pharmaceutical can itself reliably deliver due to external dependencies (exogenous factors).
To assess this, data analysis should be conducted to get practical answers:
Generally you can differentiate the competition of PT Combined Imperial Pharmaceutical by the purchase and sales perspective.
Competitors of PT Combined Imperial Pharmaceutical on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 293750) or by top product terms.
Competitors on the sales side of PT Combined Imperial Pharmaceutical (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes or by top product terms.